Loading... please wait
Anlong XU e1628186746495 - Dr. Anlong XU

Dr. Anlong XU

President, Beijing University of Chinese Medicine

Bio Current as of agosto 5, 2021

Anlong Xu was awarded a government scholarship to study in the United States after his B.S. degree from Zhongshan (Sun Yat-sen) University (SYSU) in 1985. He went to the University of Illinois at Urbana-Champaign (UIUC) in Sept. 1986 to pursue his graduate study in immunogenetics under Dr. Harris Lewin’s supervision and obtained his Ph.D. from UIUC in 1992. Dr. Xu then did his postdoctoral research in Dr. Helen M. Ranney’s lab of the Department of Medicine at the University of California, San Diego for 2 years and then joined a San Diego-based Alliance Pharmaceutical Corp from 1994-1996 and worked on new drug discovery. After 10 years of study and research work in the U.S., he joined the faculty of Department of Biochemistry at College of Life Sciences, Sun Yat-sen (Zhongshan) University, his alma mater, in 1996. Dr. Xu currently is a professor in molecular biology and immunology and President of Beijing University of Chinese Medicine (BUCM) since 2013. Before BUCM, Dr. Xu was appointed to Vice-President for research and development of SYSU in 2008 after serving as Dean of the College of Life Sciences for 9 years. Dr. Xu has published about 200 papers in peer-reviewed international journals as the corresponding author, such as Nature, Cell, N Engl J Med, Lancet, J Hepatol, Nat Cell Biol , Cell Res, Nat Commun, Genome Res, Sci Signal, Am J Hum Genet, PNAS, J Immunol, J Biol Chem. Dr. Xu is currently member of American Association of Immunologist, American Association for the Advancement of Science, Chinese Society of Biochemistry and Molecular Biology and Chinese Society of Immunology, and used to serve as President of Guangdong Society of Biochemistry and Molecular Biology and Vice-President of International Society for Developmental and Comparative Immunology. He used to serve on the Editorial Board for Annual Review of Animal Bioscience, and currently serves on the Editorial Board for the following journals: BMC Genomics, Animal Biotechnology, National Review of Sciences, and as Editor-of Chief for Journal of Traditional Chinese Medical Sciences. His main research is focusing on understanding the origin and evolution of vertebrate immune system as well as discovering new drugs based on basic researches, particularly for the immune regulation of TCM diseases.